Platelet count and sCD40L concentrations in plasma of patients before and after correction of the platelet count
. | Platelet count before treatment × 109/L . | Platelet count after treatment, × 109/L . | sCD40L concentrations before treatment, ng/mL . | sCD40L concentrations after treatment, ng/mL . |
---|---|---|---|---|
Patient 1 with ITP | 17 | 236 | 2.5 | 25.5 |
Patient 2 with ITP | 29 | 622 | 2 | 40 |
Patient 3 with RT | 492 | 365 | 17 | 5.3 |
Patient 4 with RT | 511 | 261 | 29 | 2.6 |
Patient 5 with ET | 1500 | 925 | 13 | 7 |
Patient 6 with ET | 1100 | 500 | 39 | 6 |
. | Platelet count before treatment × 109/L . | Platelet count after treatment, × 109/L . | sCD40L concentrations before treatment, ng/mL . | sCD40L concentrations after treatment, ng/mL . |
---|---|---|---|---|
Patient 1 with ITP | 17 | 236 | 2.5 | 25.5 |
Patient 2 with ITP | 29 | 622 | 2 | 40 |
Patient 3 with RT | 492 | 365 | 17 | 5.3 |
Patient 4 with RT | 511 | 261 | 29 | 2.6 |
Patient 5 with ET | 1500 | 925 | 13 | 7 |
Patient 6 with ET | 1100 | 500 | 39 | 6 |
Platelet count and plasma sCD40L were measured in 2 patients with ITP, 2 with RT, and 2 with ET at diagnosis and after treatment. Treatments were intravenous immunoglobulins for patients 1 and 2, antibiotherapy for patient 3, corticotherapy for patient 4, and hydroxyurea for patients 5 and 6.